Your Health – Bringing Solutions to Patients
The past years have seen tremendous progress in biopharmaceutical research and medical technologies, bringing solutions to patients all over the EU. This is particularly true in the domain of rare diseases.
This is thanks to a combination of science and incentives to develop medicinal products for patients and the industry’s relentless dedication to increasing the research and development into new therapeutic solutions.
The 900 research-oriented companies we represent directly and via national associations are also at the leading edge in personalised medicine, medical technologies and advanced therapies such as cell and gene therapies.
These treatments and companies are the future of healthcare, bridging medical gaps for patients in need.